tumour markers in gastrointestinal malignancy: what use to the clinician

Clicks: 128
ID: 151220
1992
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #152 of 250 articles by views in indian journal of pharmacology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 250 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
A number of tumour ma rkers have been identified in patients with gastrointestinal malignancies. Although these markers have limited clinical application, a knowledge of their use and shortcomings will help prepare for newer applications in gastrointestinal oncology. Tumour markers recently have been used as a serological means of monitoring gastrointestinal malignancy for recurrence and have been studied experimentally by radionuclcotidc imaging using radiolabelled markers. More recently, the use of tumour antigens as specific cancer vaccines has attracted the attention of gastrointestinal oncologists as therapeutic agents.
Reference Key
yacyshyn1992canadiantumour Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;Bruce R Yacyshyn;Grant D MacLean
Journal indian journal of pharmacology
Year 1992
DOI
10.1155/1992/156872
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.